(This article has been updated to clarify the financial projection for Cresco was made by an analyst, not released by Cresco Labs.)
While the cannabis industry has experienced massive growth over the past 12 months, few companies have seen early success in profitability to date.
How has the Chicago company achieved what so few others have?
CEO Charlie Bachtell will join MJBizDaily Investor Intelligence Editor Lisa Bernard-Kuhn on Wednesday, March 13, at 2 p.m. ET/11 a.m. PT to discuss the company’s early success – and what he believes are important indicators for investors evaluating opportunities.
The Executive Webcast is part of Investor Intelligence’s premium package. Learn more at mjbizdaily.com/investing.
The pandemic pivot and how cannabis companies reacted to COVID-19.
Great, thanks for the info. Now I have a good idea when to start shorting these drug dealers. I mean all they do is talk about money and profit not patients. These guy’s are just legal drug dealers. And when the con wears off, the stock price will tank. It’ll be the race to the bottom. No worries, the free market canna vendors will replace the void.
u mad?
Haha. Bless your heart David Smitt. You need to do more research. You will find that marijuana is not a drug but rather a plant that can help people medically.
Please do and advise your friends to do the same. Love a good short squeeze.